{"links": [{"source": 0, "target": "t797", "value": "None"}, {"source": 0, "target": "t787", "value": "None"}, {"source": 0, "target": "t795", "value": "None"}, {"source": 0, "target": "t5538", "value": "None"}, {"source": 0, "target": "t5548", "value": "None"}, {"source": 0, "target": "t5546", "value": "None"}, {"source": "t797", "target": "t798", "value": "None"}, {"source": "t797", "target": "t803", "value": "None"}, {"source": "t797", "target": "t799", "value": "None"}, {"source": "t787", "target": "t788", "value": "None"}, {"source": "t787", "target": "t796", "value": "None"}, {"source": "t5538", "target": "t5539", "value": "None"}, {"source": "t5538", "target": "t5547", "value": "None"}, {"source": "t5548", "target": "t5549", "value": "None"}, {"source": "t5548", "target": "t5550", "value": "None"}, {"source": "t5548", "target": "t5554", "value": "None"}, {"source": "t798", "target": "t800", "value": "None"}, {"source": "t798", "target": "t801", "value": "None"}, {"source": "t788", "target": "t789", "value": "None"}, {"source": "t5539", "target": "t5540", "value": "None"}, {"source": "t5549", "target": "t5551", "value": "None"}, {"source": "t5549", "target": "t5552", "value": "None"}, {"source": "t800", "target": "t802", "value": "None"}, {"source": "t801", "target": "t802", "value": "None"}, {"source": "t789", "target": "t790", "value": "None"}, {"source": "t5540", "target": "t5541", "value": "None"}, {"source": "t5551", "target": "t5553", "value": "None"}, {"source": "t5552", "target": "t5553", "value": "None"}, {"source": "t790", "target": "t791", "value": "None"}, {"source": "t5541", "target": "t5542", "value": "None"}, {"source": "t791", "target": "t792", "value": "None"}, {"source": "t5542", "target": "t5543", "value": "None"}, {"source": "t792", "target": "t793", "value": "None"}, {"source": "t5543", "target": "t5544", "value": "None"}, {"source": "t793", "target": "t794", "value": "None"}, {"source": "t5544", "target": "t5545", "value": "None"}], "nodes": [{"category": "disease", "id": 0, "name": "Cervical_cancer", "x": "100", "y": "50", "fixed": "true", "draggable": "true", "value": {"name": "Cervical_cancer"}}, {"category": "treatment", "id": "t797", "name": "person in primary care with symptoms that may suggest cancer", "draggable": "true", "value": {"name": "person in primary care with symptoms that may suggest cancer", "type": "cancer ralated", "time": "", "intention": "", "description": "title:person in primary care with symptoms that may suggest cancer", "drug": {}}}, {"category": "treatment", "id": "t787", "name": "person aged 18 or over with suspected lung cancer", "draggable": "true", "value": {"name": "person aged 18 or over with suspected lung cancer", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person aged 18 or over with suspected lung cancer", "drug": {}}}, {"category": "treatment", "id": "t795", "name": "raising awareness, service organisation and audit", "draggable": "true", "value": {"name": "raising awareness, service organisation and audit", "type": "information and support", "time": "", "intention": "", "description": "title:raising awareness, service organisation and audithead:Raising awareness, service organisation and auditThe public needs to be better informed of the symptoms and signs that are characteristic of lung cancer, through coordinated campaigning to raise awareness.Rapid access clinics (previously known as early diagnosis clinics) should be provided where possible for the investigation of patients with suspected lung cancer, because they are associated with faster diagnosis and less patient anxiety.All cancer units/centres should have one or more trained lung cancer clinical nurse specialists to see patients before and after diagnosis, to provide continuing support, and to facilitate communication between the secondary care team (including the MDT), the patient s GP, the community team and the patient. Their role includes helping patients to access advice and support whenever they need it.Every cancer network should have a system of rapid access to PET-CT scanning for eligible patients.Every cancer network should have at least one centre with EBUS and/or EUS to ensure timely access.Every cancer network should ensure that patients have rapid access to a team capable of providing interventional endobronchial treatments. The local test performance of non-ultrasound-guided TBNA, EBUS and EUS-guided FNA should be the subject of audit.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.1Public awareness4Lung cancer clinical nurse specialist6Investigations15Palliative interventionsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5538", "name": "person aged 18 or over with suspected lung cancer", "draggable": "true", "value": {"name": "person aged 18 or over with suspected lung cancer", "type": "disease name and patient related", "time": "", "intention": "", "description": "title:person aged 18 or over with suspected lung cancer", "drug": {}}}, {"category": "treatment", "id": "t5548", "name": "person in primary care with symptoms that may suggest cancer", "draggable": "true", "value": {"name": "person in primary care with symptoms that may suggest cancer", "type": "cancer ralated", "time": "", "intention": "", "description": "title:person in primary care with symptoms that may suggest cancer", "drug": {}}}, {"category": "treatment", "id": "t5546", "name": "raising awareness, service organisation and audit", "draggable": "true", "value": {"name": "raising awareness, service organisation and audit", "type": "information and support", "time": "", "intention": "", "description": "title:raising awareness, service organisation and audithead:Raising awareness, service organisation and auditThe public needs to be better informed of the symptoms and signs that are characteristic of lung cancer, through coordinated campaigning to raise awareness.Rapid access clinics (previously known as early diagnosis clinics) should be provided where possible for the investigation of patients with suspected lung cancer, because they are associated with faster diagnosis and less patient anxiety.All cancer units/centres should have one or more trained lung cancer clinical nurse specialists to see patients before and after diagnosis, to provide continuing support, and to facilitate communication between the secondary care team (including the MDT), the patient s GP, the community team and the patient. Their role includes helping patients to access advice and support whenever they need it.Every cancer network should have a system of rapid access to PET-CT scanning for eligible patients.Every cancer network should have at least one centre with EBUS and/or EUS to ensure timely access.Every cancer network should ensure that patients have rapid access to a team capable of providing interventional endobronchial treatments. The local test performance of non-ultrasound-guided TBNA, EBUS and EUS-guided FNA should be the subject of audit.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.1Public awareness4Lung cancer clinical nurse specialist6Investigations15Palliative interventionsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t798", "name": "information and support", "draggable": "true", "value": {"name": "information and support", "type": "information and support", "time": "", "intention": "", "description": "title:information and supporthead:Information and supportDiscuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.  When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).  Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.  Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information (see also what NICE says on patient experience in adult NHS services).  The information given to people with suspected cancer and their families and/or carers should cover, among other issues: where the person is being referred to how long they will have to wait for the appointment how to obtain further information about the type of cancer suspected or help before the specialist appointment what to expect from the service the person will be attending what type of tests may be carried out, and what will happen during diagnostic procedures how long it will take to get a diagnosis or test results whether they can take someone with them to the appointment  who to contact if they do not receive confirmation of an appointment other sources of support.  Provide information that is appropriate for the person in terms of language, ability and culture, recognising the potential for different cultural meanings associated with the possibility of cancer.  Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer. For more information on information sharing, see what NICE says on enabling patients to actively participate in their care in patient experience in adult NHS services.  Reassure people in the safety netting group (see referral and safety netting) who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.  Explain to people who are being offered safety netting (see referral and safety netting) which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.  When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist. If the person has additional support needs because of their personal circumstances, inform the specialist (with the person s agreement). Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.Suspected cancer4Encouraging attendance at cancer servicesSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t803", "name": "patient experience", "draggable": "true", "value": {"name": "patient experience", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience", "drug": {}}}, {"category": "treatment", "id": "t799", "name": "continuing education", "draggable": "true", "value": {"name": "continuing education", "type": "treatment related", "time": "", "intention": "", "description": "title:continuing educationhead:Continuing educationTake part in continuing education, peer review and other activities to improve and maintain clinical consulting, reasoning and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t788", "name": "symptoms and signs indicating urgent chest x ray and urgent and immediate referral", "draggable": "true", "value": {"name": "symptoms and signs indicating urgent chest x ray and urgent and immediate referral", "type": "sign and symptom related", "time": "", "intention": "", "description": "title:symptoms and signs indicating urgent chest x-ray and urgent and immediate referralhead:Symptoms and signs indicating urgent chest X-ray and urgent and immediate referralRefer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for lung cancer if they: have chest X-ray findings that suggest lung cancer or are aged 40 and over with unexplained haemoptysis.Offer an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer in people aged 40 and over if they have 2 or more of the following unexplained symptoms, or if they have ever smoked and have 1 or more of the following unexplained symptoms: cough fatigue shortness of breath chest pain weight loss appetite loss.Consider an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer in people aged 40 and over with any of the following: persistent or recurrent chest infection  finger clubbing  supraclavicular lymphadenopathy or persistent cervical lymphadenopathy  chest signs consistent with lung cancer  thrombocytosis.All patients with a likely diagnosis of lung cancer should be referred to a member of a lung cancer MDT (usually a chest physician).Where a chest X-ray has been requested in primary or secondary care and is incidentally suggestive of lung cancer, a second copy of the radiologist s report should be sent to a designated member of the lung cancer MDT, usually the chest physician. The MDT should have a mechanism in place to follow up these reports to enable the patient s GP to have a management plan in place. For further information, see what NICE says on respiratory conditions.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.2Appointment with a cancer specialist3Chest X-ray reportSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12CG121", "drug": {}}}, {"category": "treatment", "id": "t796", "name": "patient experience in adult nhs services", "draggable": "true", "value": {"name": "patient experience in adult nhs services", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience in adult nhs services", "drug": {}}}, {"category": "treatment", "id": "t5539", "name": "symptoms and signs indicating urgent chest x ray and urgent and immediate referral", "draggable": "true", "value": {"name": "symptoms and signs indicating urgent chest x ray and urgent and immediate referral", "type": "sign and symptom related", "time": "", "intention": "", "description": "title:symptoms and signs indicating urgent chest x-ray and urgent and immediate referralhead:Symptoms and signs indicating urgent chest X-ray and urgent and immediate referralRefer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for lung cancer if they: have chest X-ray findings that suggest lung cancer or are aged 40 and over with unexplained haemoptysis.Offer an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer in people aged 40 and over if they have 2 or more of the following unexplained symptoms, or if they have ever smoked and have 1 or more of the following unexplained symptoms: cough fatigue shortness of breath chest pain weight loss appetite loss.Consider an urgent chest X-ray (to be performed within 2 weeks) to assess for lung cancer in people aged 40 and over with any of the following: persistent or recurrent chest infection  finger clubbing  supraclavicular lymphadenopathy or persistent cervical lymphadenopathy  chest signs consistent with lung cancer  thrombocytosis.All patients with a likely diagnosis of lung cancer should be referred to a member of a lung cancer MDT (usually a chest physician).Where a chest X-ray has been requested in primary or secondary care and is incidentally suggestive of lung cancer, a second copy of the radiologist s report should be sent to a designated member of the lung cancer MDT, usually the chest physician. The MDT should have a mechanism in place to follow up these reports to enable the patient s GP to have a management plan in place. For further information, see what NICE says on respiratory conditions.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.2Appointment with a cancer specialist3Chest X-ray reportSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12CG121", "drug": {}}}, {"category": "treatment", "id": "t5547", "name": "patient experience in adult nhs services", "draggable": "true", "value": {"name": "patient experience in adult nhs services", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience in adult nhs services", "drug": {}}}, {"category": "treatment", "id": "t5549", "name": "information and support", "draggable": "true", "value": {"name": "information and support", "type": "information and support", "time": "", "intention": "", "description": "title:information and supporthead:Information and supportDiscuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.  When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).  Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.  Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information (see also what NICE says on patient experience in adult NHS services).  The information given to people with suspected cancer and their families and/or carers should cover, among other issues: where the person is being referred to how long they will have to wait for the appointment how to obtain further information about the type of cancer suspected or help before the specialist appointment what to expect from the service the person will be attending what type of tests may be carried out, and what will happen during diagnostic procedures how long it will take to get a diagnosis or test results whether they can take someone with them to the appointment  who to contact if they do not receive confirmation of an appointment other sources of support.  Provide information that is appropriate for the person in terms of language, ability and culture, recognising the potential for different cultural meanings associated with the possibility of cancer.  Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer. For more information on information sharing, see what NICE says on enabling patients to actively participate in their care in patient experience in adult NHS services.  Reassure people in the safety netting group (see referral and safety netting) who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.  Explain to people who are being offered safety netting (see referral and safety netting) which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.  When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist. If the person has additional support needs because of their personal circumstances, inform the specialist (with the person s agreement). Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.Suspected cancer4Encouraging attendance at cancer servicesSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t5550", "name": "continuing education", "draggable": "true", "value": {"name": "continuing education", "type": "treatment related", "time": "", "intention": "", "description": "title:continuing educationhead:Continuing educationTake part in continuing education, peer review and other activities to improve and maintain clinical consulting, reasoning and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t5554", "name": "patient experience", "draggable": "true", "value": {"name": "patient experience", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience", "drug": {}}}, {"category": "treatment", "id": "t800", "name": "site or type of suspected cancer", "draggable": "true", "value": {"name": "site or type of suspected cancer", "type": "treatment related", "time": "", "intention": "", "description": "title:site or type of suspected cancer", "drug": {}}}, {"category": "treatment", "id": "t801", "name": "symptoms and findings", "draggable": "true", "value": {"name": "symptoms and findings", "type": "treatment related", "time": "", "intention": "", "description": "title:symptoms and findings", "drug": {}}}, {"category": "treatment", "id": "t789", "name": "information and support", "draggable": "true", "value": {"name": "information and support", "type": "information and support", "time": "", "intention": "", "description": "title:information and supporthead:Information and supportEnsure that a lung cancer clinical nurse specialist is available at all stages of care to support patients and carers.subhead:Effective communication with patientsFind out what the patient knows about their condition without assuming a level of knowledge. Provide patients with the opportunity to discuss tests and treatment options in a private environment, with the support of carers, and time to make an informed choice.Offer accurate and easy-to-understand information to patients and their carers. Explain the tests and treatment options, including potential survival benefits, side effects and effect on symptoms.Consider tailor-made decision aids to help patients to: understand the probable outcomes of treatment options consider the personal value they place on benefits versus harms of treatment options feel supported in decision-making move through the steps towards making a decision take part in decisions about their healthcare.Offer patients a record of all discussions that have taken place with them and a copy of any correspondence with other healthcare professionals. Ensure all communications are worded in such a way to assist understanding.Respect the patient s choice if they do not wish to confront future issues.Avoid giving patients unexpected bad news by letter. Only give unexpected bad news by phone in exceptional circumstances.Offer to discuss end-of-life care with the patient sensitively and when appropriate. Wherever possible, avoid leaving this discussion until the terminal stages of the illness.Document discussions with the patient about end-of-life care. In particular, document: specific concerns of the patient their understanding of their illness and its prognosis  important values or personal goals for care  their preferences for the types of care or treatment that may be beneficial in the future and their availability.subhead:Effective communication among the multidisciplinary teamShare information between healthcare professionals about: any problems the patient has the management plan what the patient has been told what the patient has understood (where possible) the involvement of other agencies any advance decision made by the patient.The care of all patients with a working diagnosis of lung cancer should be discussed at a lung cancer MDT meeting.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.4Lung cancer clinical nurse specialist5Holistic needs assessmentSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5540", "name": "information and support", "draggable": "true", "value": {"name": "information and support", "type": "information and support", "time": "", "intention": "", "description": "title:information and supporthead:Information and supportEnsure that a lung cancer clinical nurse specialist is available at all stages of care to support patients and carers.subhead:Effective communication with patientsFind out what the patient knows about their condition without assuming a level of knowledge. Provide patients with the opportunity to discuss tests and treatment options in a private environment, with the support of carers, and time to make an informed choice.Offer accurate and easy-to-understand information to patients and their carers. Explain the tests and treatment options, including potential survival benefits, side effects and effect on symptoms.Consider tailor-made decision aids to help patients to: understand the probable outcomes of treatment options consider the personal value they place on benefits versus harms of treatment options feel supported in decision-making move through the steps towards making a decision take part in decisions about their healthcare.Offer patients a record of all discussions that have taken place with them and a copy of any correspondence with other healthcare professionals. Ensure all communications are worded in such a way to assist understanding.Respect the patient s choice if they do not wish to confront future issues.Avoid giving patients unexpected bad news by letter. Only give unexpected bad news by phone in exceptional circumstances.Offer to discuss end-of-life care with the patient sensitively and when appropriate. Wherever possible, avoid leaving this discussion until the terminal stages of the illness.Document discussions with the patient about end-of-life care. In particular, document: specific concerns of the patient their understanding of their illness and its prognosis  important values or personal goals for care  their preferences for the types of care or treatment that may be beneficial in the future and their availability.subhead:Effective communication among the multidisciplinary teamShare information between healthcare professionals about: any problems the patient has the management plan what the patient has been told what the patient has understood (where possible) the involvement of other agencies any advance decision made by the patient.The care of all patients with a working diagnosis of lung cancer should be discussed at a lung cancer MDT meeting.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.4Lung cancer clinical nurse specialist5Holistic needs assessmentSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5551", "name": "site or type of suspected cancer", "draggable": "true", "value": {"name": "site or type of suspected cancer", "type": "treatment related", "time": "", "intention": "", "description": "title:site or type of suspected cancer", "drug": {}}}, {"category": "treatment", "id": "t5552", "name": "symptoms and findings", "draggable": "true", "value": {"name": "symptoms and findings", "type": "treatment related", "time": "", "intention": "", "description": "title:symptoms and findings", "drug": {}}}, {"category": "treatment", "id": "t802", "name": "referral and safety netting", "draggable": "true", "value": {"name": "referral and safety netting", "type": "treatment related", "time": "", "intention": "", "description": "title:referral and safety nettinghead:Referral and safety nettingsubhead:ReferralDiscussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.  Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.  Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.  Use local referral proformas if these are in use.  Once the decision to refer has been made, make sure that the referral is made within 1 working day.  Persistent parental concern and anxietyTake into account the insight and knowledge of parents and carers when considering making a referral for suspected cancer in a child or young person. Consider referral for children if their parent or carer has persistent concern or anxiety about the child s symptoms, even if the symptoms are most likely to have a benign cause. Waiting periods and missed appointmentsPut in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.  Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.  subhead:Safety nettingSafety netting is the active monitoring in primary care of people who have presented with symptoms. It has 2 separate aspects: timely review and action after investigations active monitoring of symptoms in people at low risk (but not no risk) of having cancer to see if their risk of cancer changes.Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces. Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be: planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist or worsen.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t790", "name": "advice on smoking cessation", "draggable": "true", "value": {"name": "advice on smoking cessation", "type": "information and support", "time": "", "intention": "", "description": "title:advice on smoking cessationhead:Advice on smoking cessationAdvise patients to stop smoking as soon as the diagnosis of lung cancer is suspected and tell them why this is important.Inform patients that smoking increases the risk of pulmonary complications after lung cancer surgery. Offer nicotine replacement therapy and other therapies to help patients to stop smoking in line with NICE s recommendations on stop smoking pharmacotherapies and other treatments.Do not postpone surgery for lung cancer to allow patients to stop smoking.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5541", "name": "advice on smoking cessation", "draggable": "true", "value": {"name": "advice on smoking cessation", "type": "information and support", "time": "", "intention": "", "description": "title:advice on smoking cessationhead:Advice on smoking cessationAdvise patients to stop smoking as soon as the diagnosis of lung cancer is suspected and tell them why this is important.Inform patients that smoking increases the risk of pulmonary complications after lung cancer surgery. Offer nicotine replacement therapy and other therapies to help patients to stop smoking in line with NICE s recommendations on stop smoking pharmacotherapies and other treatments.Do not postpone surgery for lung cancer to allow patients to stop smoking.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5553", "name": "referral and safety netting", "draggable": "true", "value": {"name": "referral and safety netting", "type": "treatment related", "time": "", "intention": "", "description": "title:referral and safety nettinghead:Referral and safety nettingsubhead:ReferralDiscussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.  Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.  Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.  Use local referral proformas if these are in use.  Once the decision to refer has been made, make sure that the referral is made within 1 working day.  Persistent parental concern and anxietyTake into account the insight and knowledge of parents and carers when considering making a referral for suspected cancer in a child or young person. Consider referral for children if their parent or carer has persistent concern or anxiety about the child s symptoms, even if the symptoms are most likely to have a benign cause. Waiting periods and missed appointmentsPut in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.  Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.  subhead:Safety nettingSafety netting is the active monitoring in primary care of people who have presented with symptoms. It has 2 separate aspects: timely review and action after investigations active monitoring of symptoms in people at low risk (but not no risk) of having cancer to see if their risk of cancer changes.Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces. Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be: planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist or worsen.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG12", "drug": {}}}, {"category": "treatment", "id": "t791", "name": "diagnosis and staging of lung cancer", "draggable": "true", "value": {"name": "diagnosis and staging of lung cancer", "type": "cancer ralated", "time": "", "intention": "", "description": "title:diagnosis and staging of lung cancer", "drug": {}}}, {"category": "treatment", "id": "t5542", "name": "diagnosis and staging of lung cancer", "draggable": "true", "value": {"name": "diagnosis and staging of lung cancer", "type": "cancer ralated", "time": "", "intention": "", "description": "title:diagnosis and staging of lung cancer", "drug": {}}}, {"category": "treatment", "id": "t792", "name": "management", "draggable": "true", "value": {"name": "management", "type": "treatment related", "time": "", "intention": "", "description": "title:management", "drug": {}}}, {"category": "treatment", "id": "t5543", "name": "management", "draggable": "true", "value": {"name": "management", "type": "treatment related", "time": "", "intention": "", "description": "title:management", "drug": {}}}, {"category": "treatment", "id": "t793", "name": "follow up", "draggable": "true", "value": {"name": "follow up", "type": "treatment related", "time": "", "intention": "", "description": "title:follow-uphead:Follow-upOffer all patients an initial specialist follow-up appointment within 6 weeks of completing treatment to discuss ongoing care. Offer regular appointments thereafter, rather than relying on patients requesting appointments when they experience symptoms.Offer protocol-driven follow-up led by a lung cancer clinical nurse specialist as an option for patients with a life expectancy of more than 3 months.Ensure that patients know how to contact the lung cancer clinical nurse specialist involved in their care between their scheduled hospital visits.The opinions and experiences of lung cancer patients and carers should be collected and used to improve the delivery of lung cancer services. Patients should receive feedback on any action taken as a result of such surveys.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.4Lung cancer clinical nurse specialist14Optimal follow-up regimeSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t5544", "name": "follow up", "draggable": "true", "value": {"name": "follow up", "type": "treatment related", "time": "", "intention": "", "description": "title:follow-uphead:Follow-upOffer all patients an initial specialist follow-up appointment within 6 weeks of completing treatment to discuss ongoing care. Offer regular appointments thereafter, rather than relying on patients requesting appointments when they experience symptoms.Offer protocol-driven follow-up led by a lung cancer clinical nurse specialist as an option for patients with a life expectancy of more than 3 months.Ensure that patients know how to contact the lung cancer clinical nurse specialist involved in their care between their scheduled hospital visits.The opinions and experiences of lung cancer patients and carers should be collected and used to improve the delivery of lung cancer services. Patients should receive feedback on any action taken as a result of such surveys.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.4Lung cancer clinical nurse specialist14Optimal follow-up regimeSourcesThe NICE guidance that was used to create this part of the interactive flowchart. CG121", "drug": {}}}, {"category": "treatment", "id": "t794", "name": "supportive and palliative care", "draggable": "true", "value": {"name": "supportive and palliative care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:supportive and palliative care", "drug": {}}}, {"category": "treatment", "id": "t5545", "name": "supportive and palliative care", "draggable": "true", "value": {"name": "supportive and palliative care", "type": "cancer ralated", "time": "", "intention": "", "description": "title:supportive and palliative care", "drug": {}}}]}